Business Context and Reporting Period
This Form 6-K filing by Garden Stage Limited covers the month of June 2025. The report details a registered direct offering of ordinary shares completed in mid-June 2025.
Key Financial Metrics
- Capital Raised: The Company issued 6,100,000 ordinary shares at a purchase price of $0.60 per share.
- Net Proceeds: Approximately $3,580,000 was received after deducting estimated offering expenses.
- Use of Proceeds: Funds are designated for working capital and general corporate purposes.
- Revenue and Profit: The filing text does not provide a clear value for revenue, profit, cash flow, margins, or debt levels.
Material Changes
The primary material change reported is the increase in share count and equity capital resulting from the June 2025 Registered Direct Offering. No comparative financial data or changes in operating metrics versus prior periods are provided in this document.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the Company's future business, plans, and strategies. Management explicitly states that actual results may differ materially from these projections due to inherent uncertainties and risks. Specific risks are referenced in the Company's annual report on Form 20-F for the year ended December 31, 2024. No specific financial guidance or outlook figures are included in this text.
Investor Verification Checklist
- Verify the final closing date and exact net proceeds received from the June 2025 Registered Direct Offering.
- Review the Form 20-F for the year ended December 31, 2024, to assess the specific risk factors mentioned.
- Confirm the dilution impact of the 6,100,000 newly issued shares on existing shareholders.
- Check subsequent filings for updates on the deployment of the $3,580,000 in net proceeds.